​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 28.44% institutional investors, 2.04% insiders, and 69.52% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.19% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.43% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics28.44%2.04%69.52%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.40M12.19%$3.20B
Blackrock5.47M11.64%$1.74B
Vanguard group4.18M9.53%$2.03B
Avoro capital advisors2.63M5.94%$1.56B
Wellington management group llp2.26M5.11%$1.34B
State street1.84M4.16%$1.09B
Renaissance1.79M4.03%$1.06B
Geode capital management1.23M2.78%$729.92M
Janus henderson group866.93K1.96%$514.02M
Aqr capital management826.23K1.87%$486.42M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management84.28K19.55%$49.98M
Avoro capital advisors2.63M15.34%$1.56B
Tri locum partners lp122.19K11.77%$51.22M
Darwin global management748.55K8.83%$317.62M
Nepsis42.19K8.38%$25.02M
Eversept partners, lp264.27K8.26%$156.71M
First turn management104.73K6.94%$62.10M
Nitorum capital11.46K5.97%$6.80M
Palo alto investors lp62.81K5.70%$37.24M
Summit street capital management56.87K4.77%$33.72M

Top Buyers

HolderShares% AssetsChange
Darwin global management748.55K8.83%748.55K
Norges bank602.19K0.03%602.19K
Vanguard fiduciary trust267.98K0.04%267.98K
Blackrock funding, inc. /de5.40M0.06%228.88K
Citadel advisors360.64K0.03%173.48K

Top Sellers

HolderShares% AssetsChange
Aqr capital management826.23K0.22%-455.47K
Vaughan nelson investment management---328.78K
Vanguard group4.18M0.03%-242.59K
Amundi129.99K0.02%-232.84K
Jane street group2.76K0.00%-214.06K

New Positions

HolderShares% AssetsChangeValue
Darwin global management748.55K8.83%748.55K$317.62M
Norges bank602.19K0.03%602.19K$293.42M
Vanguard fiduciary trust267.98K0.04%267.98K$158.91M
Tri locum partners lp122.19K11.77%122.19K$51.22M
Bowen hanes85.00K1.23%85.00K$50.40M

Sold Out

HolderChange
Financial gravity asset management-1.00
Raleigh capital management-1.00
Financial synergies wealth advisors-1.00
Tfo-tdc-2.00
Opal wealth advisors-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026482-43.29%12,599,762-69.70%280.32%218-53.81%174-33.59%
Dec 31, 2025589-21.05%26,681,650-34.76%600.74%320-4.76%186-33.33%
Sep 30, 20257085.20%40,294,923-2.97%891.05%319-10.64%26425.71%
Jun 30, 20256810.59%43,719,199-1.26%961.00%3584.99%214-4.89%
Mar 31, 2025670-2.33%43,709,344-0.77%971.00%338-9.38%2236.70%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.45M3.43%-736.00
Vanguard Total Stock Mkt Idx Inv1.40M3.29%3.38K
Vanguard US Total Market Shares ETF1.41M3.14%1.06K
Vanguard Small Cap Index1.01M2.38%-2.15K
Vanguard Health Care Inv855.74K2.02%-119.00K
Vanguard Small Cap Value Index Inv648.46K1.53%4.53K
Vanguard Institutional Extnd Mkt Idx Tr486.09K1.15%4.83K
Vanguard Windsor Investor Shares488.35K1.09%-40.43K
SPDR® S&P Biotech ETF424.26K0.94%945.00
Invesco S&P MidCap Quality ETF361.15K0.85%-

Recent Insider Transactions

DateNameRoleActivityValue
May 28, 2026EDGEMOND JAMES CFO AND TREASURERSell$944.49K
May 28, 2026EDGEMOND JAMES CFO AND TREASURERSell$682.30K
May 28, 2026EDGEMOND JAMES CFO AND TREASURERSell$179.67K
May 28, 2026EDGEMOND JAMES CFO AND TREASURERSell$1.10M
May 28, 2026EDGEMOND JAMES CFO AND TREASURERSell$505.43K

Insider Transactions Trends

DateBuySell
2026 Q21673
2026 Q1-459
2025 Q4-383
2025 Q3-150
2025 Q2-61

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 28.44%, followed by 2.04% insiders and 69.52% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 35.75%, which United Therapeutics falls below.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.4M shares, 12.19%), Blackrock (5.47M shares, 11.64%), and Vanguard group (4.18M shares, 9.53%). Together, they hold 33.36% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.55% of its assets in 84.28K United Therapeutics shares, valued at 49.98M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.43% of its total shares outstanding invested in 1.45M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools